Annual Short Term Debt
$24.86 M
+$21.56 M+651.63%
December 31, 2024
Summary
- As of February 23, 2025, KPTI annual short term debt is $24.86 million, with the most recent change of +$21.56 million (+651.63%) on December 31, 2024.
- During the last 3 years, KPTI annual short term debt has risen by +$22.55 million (+973.58%).
- KPTI annual short term debt is now at all-time high.
Performance
KPTI Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
N/A
December 31, 2024
Summary
- KPTI quarterly short term debt is not available.
Performance
KPTI Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
KPTI Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +651.6% | - |
| 3 y3 years | +973.6% | - |
| 5 y5 years | +1410.6% | - |
KPTI Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +973.6% | ||
| 5 y | 5-year | at high | +1410.6% | ||
| alltime | all time | at high | -100.0% |
Karyopharm Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $24.86 M(+651.6%) | - |
| Sep 2024 | - | $3.67 M(+3.5%) |
| Jun 2024 | - | $3.54 M(+3.5%) |
| Mar 2024 | - | $3.42 M(+3.5%) |
| Dec 2023 | $3.31 M(+15.2%) | $3.31 M(+3.5%) |
| Sep 2023 | - | $3.19 M(+3.6%) |
| Jun 2023 | - | $3.08 M(+3.6%) |
| Mar 2023 | - | $2.98 M(+3.7%) |
| Dec 2022 | $2.87 M(+24.0%) | $2.87 M(+3.7%) |
| Sep 2022 | - | $2.77 M(+5.9%) |
| Jun 2022 | - | $2.62 M(+6.2%) |
| Mar 2022 | - | $2.46 M(+6.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $2.32 M(+20.8%) | $2.32 M(+7.1%) |
| Sep 2021 | - | $2.16 M(+4.0%) |
| Jun 2021 | - | $2.08 M(+4.1%) |
| Mar 2021 | - | $2.00 M(+4.2%) |
| Dec 2020 | $1.92 M(+16.5%) | $1.92 M(+3.8%) |
| Sep 2020 | - | $1.85 M(+3.9%) |
| Jun 2020 | - | $1.78 M(+3.9%) |
| Mar 2020 | - | $1.71 M(+3.9%) |
| Dec 2019 | $1.65 M(>+9900.0%) | $1.65 M(+4.0%) |
| Sep 2019 | - | $1.58 M(+4.0%) |
| Jun 2019 | - | $1.52 M(+10.7%) |
| Mar 2019 | - | $1.38 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Karyopharm Therapeutics annual short term debt?
- What is the all time high annual short term debt for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual short term debt year-on-year change?
- What is the all time high quarterly short term debt for Karyopharm Therapeutics?
What is Karyopharm Therapeutics annual short term debt?
The current annual short term debt of KPTI is $24.86 M
What is the all time high annual short term debt for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual short term debt is $24.86 M
What is Karyopharm Therapeutics annual short term debt year-on-year change?
Over the past year, KPTI annual short term debt has changed by +$21.56 M (+651.63%)
What is the all time high quarterly short term debt for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly short term debt is $3.67 M